Health Condition 1: I39- Endocarditis and heart valve disorders in diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -ASA physical status III-IV - Patients able to comprehend and willing to participate. -Patients scheduled for elective cardiac surgeries (mitral /aortic/double valve surgery and/or coronary artery bypass grafting)
Exclusion criteria
Exclusion criteria: Patients refusal to participate Emergent of redo surgeries Difficult airway Morbid obesity Protocol violation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study will to measure the incidence of hypotension (fall in MAP more than 20% from the baseline value) during the first ten minutes following anaesthesia induction with etomidate versus propofol- norepinephrine combination.Timepoint: Hemodynamic parameters (MAP, SBP, DBP, and HR) will recorded at 21 time points baseline and every 30 seconds for 10 minutes after the induction agent will last injected. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome will to measure the number of time points where there will tachycardia and hypertension (heart rate and MAP rise more than 20% from the baseline value) to direct laryngoscopy and intubation in both groups or any adverse side effects seen.Timepoint: Number of time point ( measured every 30 sec) with tachycardia /hypertension to direct laryngoscopy | — |
Countries
India
Contacts
Government